{ "schemaVersion": 1, "organisationId": "O-4524251f259249b391105c5fe5c22d73", "slug": "minimed-group-inc", "name": "MINIMED GROUP INC", "updatedAt": "2026-10-02T16:25:56.358833Z", "sections": [ { "type": "OVERVIEW", "text": "MiniMed Group Inc. is a medical-technology company focused on diabetes management. It develops, manufactures, and markets automated insulin delivery systems and Smart MDI solutions, integrating insulin pumps or smart pens with glucose monitoring, dosing algorithms, software, and related services. Its stated mission is “to make every day a better day for people with diabetes.” [P169197553][P169196735]\n\nThe company’s products serve customers in more than 80 countries; it reported over 640,000 pump users as of April 2026. MiniMed reported approximately 8,000 employees globally and FY2026 revenue of $3.1 billion, with about 70% of revenue generated outside the United States. [P169196862][P169196865][P169196672]\n[P169197553][P169196735][P169196862][P169196865][P169196672]", "updatedAt": "2026-10-02T16:25:56.358833Z" }, { "type": "PRODUCTS", "text": "MiniMed’s core product is the MiniMed 780G automated insulin delivery system, which combines an insulin pump, infusion sets and reservoirs, a continuous glucose monitor (CGM), and the SmartGuard dosing algorithm. SmartGuard uses sensor glucose readings and Meal Detection to adjust or deliver correction insulin every five minutes; its glucose target can be set as low as 100 mg/dL. The system also connects with companion apps and CareLink for monitoring and data upload. [P169196658][P169196741]\n\nIts CGM products include Guardian 4, Simplera Sync, and Instinct. Simplera Sync is a disposable, all-in-one sensor described as about half the size of earlier CGMs. MiniMed Go is a smart multiple-daily-injection offering that combines the Bluetooth-enabled InPen smart insulin pen with CGM, dosing software, an app, and related services; its app provides personalized mealtime and correction-dose suggestions using CGM readings. [P169197667][P169194028][P169196659][P169196759]\n\nThe company has also described MiniMed Flex, a discreet, smartphone-controlled pump, and MiniMed Fit, a patch pump, as development or commercialization programs. In FY2026, CGMs, other consumables, software, and services collectively represented approximately 82% of revenue; the company did not provide a separate revenue percentage for each product. [P169205658][P169197165][P169196672]\n[P169196658][P169196741][P169197667][P169194028][P169196659][P169196759][P169205658][P169197165][P169196672]", "updatedAt": "2026-10-02T16:25:56.358833Z" }, { "type": "GEOGRAPHY", "text": "In FY2026, MINIMED GROUP INC reported net sales of $3.102 billion: $917 million in the U.S. (29.6%) and $2.185 billion internationally (70.4%). The company reports this geographic split at the U.S./International level, rather than by individual country. [T19716883] Its disclosed international pump-user markets include Benelux, Germany, Israel, Italy, Scandinavia, Spain, Argentina, Brazil, Poland, Russia and Saudi Arabia; these are user-presence rankings, not country-level revenue figures. [P169196845]\n\nThe company is headquartered in Northridge, California, and identifies primary internal manufacturing facilities in Northridge and Juncos, Puerto Rico. [P169196671][P169196924] It refers to a global employee base but does not disclose a geographic breakdown of employees, and does not provide a comprehensive list of sales offices. [P169196671]\n[T19716883][T19716883][T19716883][P169196845][P169196671][P169196924]", "updatedAt": "2026-10-02T16:25:56.358833Z" }, { "type": "SEGMENTS", "text": "For FY2026, MiniMed Group reported one operating and reportable segment, managed on a consolidated basis; it did not report separate business segments. The segment’s business focuses on diabetes-management products, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. [P169198145]\n\nIts offerings include Automated Insulin Delivery systems that combine pumps, infusion consumables, CGM sensors, dosing algorithms, software, and related services, and a Smart Multiple Daily Injection system combining a smart insulin pen, CGM, dosing software, applications, and services. These are product-system groupings, not separately reported segments. [P169196658][P169196659]\n\nThe sole reportable segment accounted for 100% of FY2026 revenue of $3.102 billion. The company also reported that approximately 82% of revenue—about $2.54 billion based on the rounded percentage—came collectively from CGMs, other consumables, software, and services; it did not disclose separate segment revenue for those categories. [P169198145][P169196672]\n[P169198145][P169196658][P169196659][P169196672]", "updatedAt": "2026-10-02T16:25:56.358833Z" }, { "type": "HISTORY", "text": "MiniMed traces its origins to 1983, when medical-device entrepreneur Alfred E. Mann founded the company and introduced the wearable MiniMed 502 insulin pump. The company developed successive pump models through the 1990s and launched its first continuous glucose monitoring system in 1999. [P169192871][P169194396][P169194400][https://www.minimed.com/en-us/innovation-pipeline]\n\nMedtronic acquired MiniMed in 2001. The business continued to develop diabetes technologies, including an integrated diabetes-management system in 2006, a pump with low-glucose insulin suspension in 2009, and the remote glucose monitor mySentry in 2012. In 2016, the MiniMed 670G introduced a commercially available hybrid closed-loop system; its U.S. launch followed in 2017. [P169194400][P169194402][P169194404][https://news.medtronic.com/2017-06-07-Medtronic-Initiates-U-S-Launch-of-Worlds-First-Hybrid-Closed-Loop-System-for-Type-1-Diabetes]\n\nThe FDA approved the MiniMed 780G system in 2023. In 2025, Medtronic announced plans to separate its Diabetes business, named the planned company MiniMed, and appointed Que Dallara CEO-designate. MiniMed Group, Inc. was incorporated in Delaware in 2025. The separation began with MiniMed’s March 2026 IPO and Nasdaq listing; Medtronic retained approximately 90% ownership after the offering. [P169194856][https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections][https://news.medtronic.com/2025-05-21-Medtronic-announces-intent-to-separate-Diabetes-business][https://news.medtronic.com/2025-06-12-Medtronic-announces-MiniMed-as-name-for-planned-New-Diabetes-Company][https://investors.minimed.com/2026-03-06-MiniMed-begins-trading-on-Nasdaq-Global-Select-Market][https://investors.minimed.com/2026-03-09-MiniMed-announces-closing-of-Initial-Public-Offering][https://investors.minimed.com/investor-faqs]\n[P169192871][P169194396][P169194400][https://www.minimed.com/en-us/innovation-pipeline][P169194402][P169194404][https://news.medtronic.com/2017-06-07-Medtronic-Initiates-U-S-Launch-of-Worlds-First-Hybrid-Closed-Loop-System-for-Type-1-Diabetes][P169194856][https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections][https://news.medtronic.com/2025-05-21-Medtronic-announces-intent-to-separate-Diabetes-business][https://news.medtronic.com/2025-06-12-Medtronic-announces-MiniMed-as-name-for-planned-New-Diabetes-Company][https://investors.minimed.com/2026-03-06-MiniMed-begins-trading-on-Nasdaq-Global-Select-Market][https://investors.minimed.com/2026-03-09-MiniMed-announces-closing-of-Initial-Public-Offering][https://investors.minimed.com/investor-faqs][https://www.minimed.com/en-us/innovation-pipeline][https://news.medtronic.com/2017-06-07-Medtronic-Initiates-U-S-Launch-of-Worlds-First-Hybrid-Closed-Loop-System-for-Type-1-Diabetes][https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections][https://news.medtronic.com/2025-05-21-Medtronic-announces-intent-to-separate-Diabetes-business][https://news.medtronic.com/2025-06-12-Medtronic-announces-MiniMed-as-name-for-planned-New-Diabetes-Company][https://investors.minimed.com/2026-03-06-MiniMed-begins-trading-on-Nasdaq-Global-Select-Market][https://investors.minimed.com/2026-03-09-MiniMed-announces-closing-of-Initial-Public-Offering][https://investors.minimed.com/investor-faqs]", "updatedAt": "2026-10-02T16:25:56.358833Z" } ], "sources": [ { "id": "P169197553", "href": "https://app.finbar.com/go?id=P169197553", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196735", "href": "https://app.finbar.com/go?id=P169196735", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196862", "href": "https://app.finbar.com/go?id=P169196862", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196865", "href": "https://app.finbar.com/go?id=P169196865", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196672", "href": "https://app.finbar.com/go?id=P169196672", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196658", "href": "https://app.finbar.com/go?id=P169196658", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196741", "href": "https://app.finbar.com/go?id=P169196741", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169197667", "href": "https://app.finbar.com/go?id=P169197667", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169194028", "href": "https://app.finbar.com/go?id=P169194028", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "P169196659", "href": "https://app.finbar.com/go?id=P169196659", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196759", "href": "https://app.finbar.com/go?id=P169196759", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169205658", "href": "https://app.finbar.com/go?id=P169205658", "label": "MINIMED GROUP INC — Full financial report (2026 Q 3)", "documentId": "D-1fed78a1dbb5465896c78f22277d4a40" }, { "id": "P169197165", "href": "https://app.finbar.com/go?id=P169197165", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "T19716883", "href": "https://app.finbar.com/go?id=T19716883", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196845", "href": "https://app.finbar.com/go?id=P169196845", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196671", "href": "https://app.finbar.com/go?id=P169196671", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169196924", "href": "https://app.finbar.com/go?id=P169196924", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169198145", "href": "https://app.finbar.com/go?id=P169198145", "label": "MINIMED GROUP INC — Full financial report (2026 Y)", "documentId": "D-e2dc655952d04b81b9dcb05258040921" }, { "id": "P169192871", "href": "https://app.finbar.com/go?id=P169192871", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "P169194396", "href": "https://app.finbar.com/go?id=P169194396", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "P169194400", "href": "https://app.finbar.com/go?id=P169194400", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "https://www.minimed.com/en-us/innovation-pipeline", "href": "https://www.minimed.com/en-us/innovation-pipeline", "label": "www.minimed.com" }, { "id": "P169194402", "href": "https://app.finbar.com/go?id=P169194402", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "P169194404", "href": "https://app.finbar.com/go?id=P169194404", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "https://news.medtronic.com/2017-06-07-Medtronic-Initiates-U-S-Launch-of-Worlds-First-Hybrid-Closed-Loop-System-for-Type-1-Diabetes", "href": "https://news.medtronic.com/2017-06-07-Medtronic-Initiates-U-S-Launch-of-Worlds-First-Hybrid-Closed-Loop-System-for-Type-1-Diabetes", "label": "news.medtronic.com" }, { "id": "P169194856", "href": "https://app.finbar.com/go?id=P169194856", "label": "MINIMED GROUP INC — Ipo (2026 O)", "documentId": "D-eebf7744c8cd4866a221726ea8c8fa24" }, { "id": "https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections", "href": "https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections", "label": "news.medtronic.com" }, { "id": "https://news.medtronic.com/2025-05-21-Medtronic-announces-intent-to-separate-Diabetes-business", "href": "https://news.medtronic.com/2025-05-21-Medtronic-announces-intent-to-separate-Diabetes-business", "label": "news.medtronic.com" }, { "id": "https://news.medtronic.com/2025-06-12-Medtronic-announces-MiniMed-as-name-for-planned-New-Diabetes-Company", "href": "https://news.medtronic.com/2025-06-12-Medtronic-announces-MiniMed-as-name-for-planned-New-Diabetes-Company", "label": "news.medtronic.com" }, { "id": "https://investors.minimed.com/2026-03-06-MiniMed-begins-trading-on-Nasdaq-Global-Select-Market", "href": "https://investors.minimed.com/2026-03-06-MiniMed-begins-trading-on-Nasdaq-Global-Select-Market", "label": "investors.minimed.com" }, { "id": "https://investors.minimed.com/2026-03-09-MiniMed-announces-closing-of-Initial-Public-Offering", "href": "https://investors.minimed.com/2026-03-09-MiniMed-announces-closing-of-Initial-Public-Offering", "label": "investors.minimed.com" }, { "id": "https://investors.minimed.com/investor-faqs", "href": "https://investors.minimed.com/investor-faqs", "label": "investors.minimed.com" } ] }